Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cytovance Biologics

Request full access

Manufacturing and development services for recombinant protein drug substances

Oklahoma City, United StatesFounded 2003Biotech & Life Sciences

About Cytovance Biologics

Cytovance Biologics is a biopharmaceutical contract manufacturing organization (CMO) that focuses on the production of therapeutic proteins and antibodies. The company operates in the biopharmaceutical industry, serving clients that range from small biotech firms to large pharmaceutical companies. Cytovance Biologics specializes in both mammalian cell culture and microbial fermentation, including the production of plasmid DNA (pDNA). The company offers a comprehensive suite of services, including process development, cGMP (current Good Manufacturing Practice) manufacturing, and cGMP cell banking. These services are provided from their state-of-the-art facilities in Oklahoma City, which include extensive lab space and a newly constructed greenfield facility for GMP warehousing and future manufacturing expansions. Cytovance Biologics generates revenue through contract manufacturing agreements, where clients pay for the production and development of their biopharmaceutical products. The company has also been actively involved in the production and distribution of COVID-19 vaccines, contributing to the global effort to combat the pandemic.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
180
Open positions
2
Dealroom signal
32.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biological, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2C

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Oct 2015 $206M $206M Undisclosed —
DEBT✓Debt Oct 2014 $20M — Monroe Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cytovance Biologics website traffic

Latest recorded traffic for Cytovance Biologics is 2.1K monthly website visits, down 30% over the last three months. Cytovance Biologics's team declined 25.6% over the past year.

Latest monthly visits2.1K 3-month web change-30% 1-year team growth-25.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cytovance Biologics in the Oklahoma City ecosystem

Live from Dealroom

The Cytovance Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Great Point Partners
  • Monroe Capital
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.3%
🇨🇳 China0.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cytovance Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cytovance Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.